Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Other Products by Quarter
Other Products (Cayston, Jyseleca, Letairis, Zydelig) ($M) ($M)
Gilead Sciences Other Products: $51M in Q2 2026, down 30.1% from a year earlier.
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-06) ↗
Reported in Form 10-Q / 10-K Disaggregated Revenue Note & Form 8-K Product Sales Summary.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up other Products
- Other Products (Cayston, Jyseleca, Letairis, Zydelig) — U.S. sales ($M)22 · Q2 2026
- Other Products (Cayston, Jyseleca, Letairis, Zydelig) — Europe sales ($M)8 · Q2 2026
- Other Products (Cayston, Jyseleca, Letairis, Zydelig) — Rest of World sales ($M)21 · Q2 2026
- Other Products (Cayston, Jyseleca, Letairis, Zydelig) — Worldwide YoY growth (%)-20.0% · Q2 2026
Cite this data
StockData. (2026). Gilead Sciences Other Products ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/other-misc
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.